{{不是|赤霉素}}
{{medical}}
{{noteTA
|1=zh-cn:红霉素; zh-tw:紅黴素; zh-hk:紅黴素;
}}
{{drugbox
| verifiedrevid = 464189839
| IUPAC_name = (3''R'',4''S'',5''S'',6''R'',7''R'',9''R'',11''R'',12''R'',13''S'',14''R'')-6-<br/>{[(2''S'',3''R'',4''S'',6''R'')-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-<br/>14-ethyl-7,12,13-trihydroxy-4-{[(2''R'',4''R'',5''S'',6''S'')-<br/>5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-<br/>3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
| image =Erythromycin A.svg
| width = 200
| image2 = Erythromycin_3d_structure.png
<!--Clinical data-->
| tradename = Eryc、Erythrocin，及其他<ref name=AHFS2015/>。
| Drugs.com = {{drugs.com|monograph|erythromycin}}
| MedlinePlus = a682381
| pregnancy_AU = A
| pregnancy_AU_comment = <ref name=AG2015/>
| pregnancy_US = B
| pregnancy_US_comment = <ref name=AHFS2015/>
| pregnancy_category = 
| legal_AU = S4
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = 口服、[[靜脈注射|靜脈注射]]、[[肌肉注射|肌肉注射]]、外用、[[眼藥水|眼藥水]]
<!--Pharmacokinetic data-->
| bioavailability = 30%－65%，取决於酯型
| protein_bound = 90%
| metabolism = 肝脏（少於5%的量排出时不改变）
| elimination_half-life = 1.5小时
| excretion = 膽汁
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 114-07-8
| ATC_prefix = D10
| ATC_suffix = AF02
| ATC_supplemental =  {{ATC|J01|FA01}} {{ATC|S01|AA17}} {{ATCvet|J51|FA01}}
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 42355
| PubChem = 3255
| IUPHAR_ligand = 1456
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00199
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 12041
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 63937KV33D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00140
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 532
<!--Chemical data-->
| C=37 | H=67 | N=1 | O=13
| molecular_weight = 
| smiles = CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ULGZDMOVFRHVEP-RWJQBGPGSA-N
}}
<!-- Definition and medical uses -->
'''红霉素'''（{{lang-la|'''Erythromycin'''}}）是一种[[大环内酯|大环内酯]]类的[[抗细菌药|抗生素]]<ref name=AHFS2015/>，可用於治療[[呼吸道感染|呼吸道感染]]、{{tsl|en|skin infections|皮膚感染}}、衣原體菌感染（{{lang-la|chlamydia infections}}），以及[[梅毒|梅毒]]<!-- <ref name=AHFS2015/> -->。本品也可用於預防新生兒的{{tsl|en|Group B streptococcal infection|B群鏈球菌感染}}<ref name=AHFS2015/>。紅黴素可以用於改善胃輕癱（{{lang-la|gastroparesis}}）的症狀<ref>{{cite journal | authors = Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L | title = Clinical guideline: management of gastroparesis | journal = The American Journal of Gastroenterology | volume = 108 | issue = 1 | pages = 18–37; quiz 38 | date = Jan 2013 | pmid = 23147521 | doi = 10.1038/ajg.2012.373 }}</ref>。本品可透過靜脈注射或口服給藥<ref name=AHFS2015/> 。新生兒有時會給予含有紅黴素的眼藥水，以避免新生兒結膜炎（{{lang-la|neonatal conjunctivitis}}）<ref>{{cite journal | authors = Matejcek A, Goldman RD | title = Treatment and prevention of ophthalmia neonatorum | journal = Canadian Family Physician | volume = 59 | issue = 11 | pages = 1187–90 | date = 2013-11 | pmid = 24235191 }}</ref>。

<!-- Side effects and mechanism -->
常見副作用包含腹絞痛、嘔吐，以及腹瀉等<!-- <ref name=AHFS2015/> -->。更嚴重者可能引發[[偽膜性結腸炎|偽膜性結腸炎]]、肝臟疾病、[[長QT症|長QT症]]，以及[[過敏|過敏反應]]<!-- <ref name=AHFS2015/> -->。[[青黴素|青黴素]]過敏者通常可安全服用本品<ref name=AHFS2015>{{cite web|title=Erythromycin|url=http://www.drugs.com/monograph/erythromycin.html|publisher=The American Society of Health-System Pharmacists|accessdate=2015-08-01|archive-date=2016-03-04|archive-url=https://web.archive.org/web/20160304091751/http://www.drugs.com/monograph/Erythromycin.html|dead-url=no}}</ref>。[[妊娠|妊娠]]期間用藥目前顯示安全<ref name=AG2015>{{cite web|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|work=Australian Government|date=August 23, 2015|access-date=2016-08-24|archive-date=2014-04-08|archive-url=https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|dead-url=no}}</ref>。一般認為[[母乳餵養|哺乳]]期間用藥為安全，但有研究顯示，未滿兩周的新生兒若服用本品，或母體於哺乳期間用藥，可能會增加罹患[[幽門狹窄|幽門狹窄]]的風險<ref name=Ric2013/><ref name="Kong2013">{{cite journal|vauthors=Kong YL, Tey HL |title=Treatment of acne vulgaris during pregnancy and lactation|journal=Drugs |volume=73 |issue=8 |pages=779–87|date=June 2013|pmid=23657872|doi=10.1007/s40265-013-0060-0}}</ref><ref name=Erythromycin>{{cite journal|last=Maheshwai|first=Nitin|title=Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?|journal=Archives of Disease in Childhood|date=March 2007|volume=92|issue=3|pages=271–3|pmid=17337692|url=http://adc.bmj.com/content/92/3/271|accessdate=30 August 2012|doi=10.1136/adc.2006.110007|pmc=2083424|author=|archive-url=https://web.archive.org/web/20121107021907/http://adc.bmj.com/content/92/3/271|archive-date=2012-11-07|dead-url=yes}}</ref>。紅黴素屬於[[大環內酯|大環內酯]]類抗生素，會抑制細菌的蛋白質合成<ref name=AHFS2015/>。

<!-- History, society and culture -->
紅黴素於1952年首次从一种放線菌：{{le|糖多孢红霉菌|Saccharopolyspora erythraea}}（{{lang-la|Saccharopolyspora erythraea}}）中純化出來<ref name=AHFS2015/><ref>{{cite book|last1=Vedas|first1=J. C.|name-list-format=vanc|title=Biosynthesis : polyketides and vitamins|date=2000|publisher=Springer|location=Berlin [u.a.]|isbn=9783540669692|page=52|url=https://books.google.ca/books?id=XUuFPxvfWgAC&pg=PA52|access-date=2016-08-24|archive-date=2015-09-27|archive-url=https://web.archive.org/web/20150927165149/https://books.google.ca/books?id=XUuFPxvfWgAC&pg=PA52|dead-url=no}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref>{{cite web|title=WHO Model List of Essential Medicines|format=PDF|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013|archive-date=2014-04-23|archive-url=https://web.archive.org/web/20140423005004/http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|dead-url=no}}</ref>。該藥屬於[[學名藥|學名藥]]，價格不貴<ref name=Ric2013>{{cite book|last1=Hamilton|first1=Richard J.|name-list-format=vanc|title=Tarascon pocket pharmacopoeia|date=2013|publisher=Jones & Bartlett Learning|location=[Sudbury, Mass.]|isbn=9781449673611|page=72|edition=2013 delux lab-coat ed., 14th|url=https://books.google.ca/books?id=zJay-fZCFGgC&pg=PA72|access-date=2016-08-24|archive-date=2016-03-05|archive-url=https://web.archive.org/web/20160305042644/https://books.google.ca/books?id=zJay-fZCFGgC&pg=PA72|dead-url=no}}</ref>。本品在[[发展中国家|发展中国家]]的每錠批發價約於 0.03 至 0.06 [[美元|USD]]之間<ref name=ERC2015>{{cite web|title=Erythromycin|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=ERY250T&s_year=2014&year=2014&str=250%20mg&desc=Erythromycin&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E2%2E2%2E&supplement=&class_name=%2806%2E2%2E2%2E%29Other%20antibacterials%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=23 August 2015}}{{Dead link|date=2018年6月 |bot=InternetArchiveBot |fix-attempted=no }}</ref>。
{{TOC limit|3}}

==发展历史==
{{空章节}}

==作用机理==
红霉素可以透过[[细菌|细菌]][[细胞膜|细胞膜]]，在接近供位（'''P'''位）与细菌[[核糖体|核糖体]]的[[50S亚基|50S亚基]]成可逆性结合，阻断[[转移核糖核酸|转移核糖核酸]]（t-RNA）结合在'''P'''位上，同时也阻断[[多肽|多肽]]链自受位（'''A'''位）至'''P'''位的转移，从而抑制细菌[[蛋白质|蛋白质]]合成。

==适应症==
适应症为[[细菌|细菌]][[感染|感染]]。抗菌范围与[[青黴素|青黴素]]相似；主要用于对青霉素已经产生耐药性的[[葡萄球菌|葡萄球菌]]、[[链球菌|链球菌]]、[[腹泻|腹泻]]等胃肠道反应。

==不良反应==
*可能发生胃肠道不良反应，如腹泻、恶心、呕吐等
*肝中毒（少见）
*过敏反应
==药代动力学参数==

==參見==
*[[白凡士林|白凡士林]]

==參考文獻==
{{reflist}}
{{refbegin}}
* British National Formulary "BNF 49" March 2005.
* Mims C, Dockrell HM, Goering RV, Roitt I, Wakelin D, Zuckerman M.  Chapter 33: Attacking the Enemy: Antimicrobial Agents and Chemotherapy: Macrolides. In: Medical Microbiology (3rd Edition).  London: Mosby Ltd; 2004. p 489
* Hunt,Ch.M., Watkins, P.B., Saenger, P., Stave, G.M., Barlascini, N., Watlington, Ch.O., Wright, J.T., Guzelian, P.S., (1992) Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol. Clinical Pharmacology and Therapeutics 51: 18-23
{{refend}}

==外部連結==
* [http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ERY Erythromycin bound to proteins] {{Wayback|url=http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ERY |date=20140311211307 }} in the [[蛋白質資料庫|PDB]]
*[http://v3.espacenet.com/origdoc?DB=EPODOC&IDX=US2653899&F=0&QPN=US2653899 U.S. Patent 2,653,899] {{Wayback|url=http://v3.espacenet.com/origdoc?DB=EPODOC&IDX=US2653899&F=0&QPN=US2653899 |date=20080513094443 }}
*[http://www.rxlist.com/erythromycin-ethylsuccinate-drug.htm E.E.S. (Erythromycin Ethylsuccinate) Drug Information: Uses, Side Effects, Drug Interactions and Warnings at RxList] {{Wayback|url=http://www.rxlist.com/erythromycin-ethylsuccinate-drug.htm |date=20210418055843 }}
{{-}}
{{国家基本药物目录/抗微生物药}}
{{蛋白质合成抑制剂类抗生素}}
{{抗痤疮制剂}}

[[Category:醇|Category:醇]]
[[Category:胺|Category:胺]]
[[Category:醚|Category:醚]]
[[Category:酮|酮]]
[[Category:礼来公司|Category:礼来公司]]
[[Category:大环内酯类抗生素|Category:大环内酯类抗生素]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:缺少物质图片的化学品条目|Category:缺少物质图片的化学品条目]]
[[Category:肝毒素|Category:肝毒素]]